Diclofenac Potassium

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

31 API Suppliers, 11 USDMF, 6 CEP/COS, 5 EU WC, 1 KDMF, 7 NDC API, 20 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

107 FDF Dossiers, 24 FDA Orange Book, 20 Europe, 5 Canada, 8 South Africa, 50 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 25MG

RELATED EXCIPIENT COMPANIES

5 Rochem International Inc, 17 SPI Pharma, 2 Seqens, 8 DKSH, 1 Pharm-RX Chemical, 8 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 15 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 10 Actylis, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 25 BASF, 1 Bioplus Life Sciences, 2 Clariant, 11 Corel Pharma Chem, 7 DFE Pharma, 1 Doshion Polyscience, 1 Finar, 10 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 37 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 9 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 29 Roquette, 13 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

95 Fillers, Diluents & Binders, 50 Coating Systems & Additives, 43 Direct Compression, 32 Disintegrants & Superdisintegrants, 30 Thickeners and Stabilizers, 29 Taste Masking, 28 Granulation, 28 Controlled & Modified Release, 25 Solubilizers, 24 Parenteral, 22 Co-Processed Excipients, 21 Film Formers & Plasticizers, 17 Chewable & Orodispersible Aids, 16 Lubricants & Glidants, 15 Topical, 9 Empty Capsules, 8 Emulsifying Agents, 7 API Stability Enhancers, 5 Surfactant & Foaming Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules, 4 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

13 NEWS #PharmaBuzz

13 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 6 Finished Drug Prices

MARKET PLACE

19 APIs, 5 FDF Dossiers

PATENTS & EXCLUSIVITIES

10 US Patents, 1 US Exclusivities, 1 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 1 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 20142 / DOSAGE - TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
DICLOFENAC POTASSIUM(UNII: L4D5UA6CB4) (DICLOFENAC - UNII:144O8QL0L1)	DICLOFENAC POTASSIUM	50mg

Inactive Ingredients

Ingredient Name	Novartis Pharmaceuticals Corporation
CALCIUM PHOSPHATE(97Z1WI3NDX)
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
FERRIC OXIDE RED(1K09F3G675)
MAGNESIUM STEARATE(70097M6I30)
POLYETHYLENE GLYCOL(3WJQ0SDW1A)
POVIDONE(FZ989GH94E)
SILICON DIOXIDE(ETJ7Z6XBU4)
SODIUM STARCH GLYCOLATE TYPE A POTATO(5856J3G2A2)
STARCH, CORN(O8232NY3SJ)
SUCROSE(C151H8M554)
TITANIUM DIOXIDE(15FIX9V2JP)

Drug Product Composition: Diclofenac Potassium